"Advances in genetic engineering offer transformative solutions to age-old public health challenges, but their deployment demands equal rigour in ecological safety , regulatory gov

1. Introduction

Gene drive technology, enabled by advances in genetic engineering (e.g., CRISPR-Cas9), can rapidly propagate desired traits in mosquito populations, offering a potentially transformative tool for malaria control.

2. Transformative Potential for Public Health

• Vector suppression/modification: Gene drives can reduce mosquito populations or render them incapable of transmitting Plasmodium.
• Cost-effective and sustainable: One-time or limited releases may have long-term impact, reducing dependence on insecticides.
• Addressing resistance: Can overcome insecticide and drug resistance challenges.

3. Ecological Safety Concerns

• Irreversibility: Self-propagating nature makes recall difficult once released.
• Ecosystem disruption: Elimination or alteration of mosquito species may affect food chains and biodiversity.
• Gene flow risks: Unintended spread across borders or to non-target species.

4. Regulatory Governance Challenges

• Inadequate frameworks: Existing biosafety regulations are not fully equipped for gene drives.
• Transboundary implications: Need for international coordination and liability mechanisms.
• Adaptive regulation: Continuous monitoring and phased testing (lab → field trials).

5. Community Consent and Ethical Dimensions

• Informed consent: Affected communities must be engaged meaningfully in decision-making.
• Equity concerns: Benefits should reach vulnerable populations without exploitation.
• Trust and transparency: Addressing fears, misinformation, and ethical concerns is critical.

6. Conditions for Safe and Equitable Application

• Robust risk assessment and containment strategies before release.
• Phased trials with independent oversight and global best practices (WHO guidance).
• Strong legal and institutional frameworks at national and international levels.
• Community engagement and participatory governance ensuring local acceptance.
• Reversibility research and monitoring systems to mitigate unintended effects.

7. Conclusion

While gene drive technology holds immense promise for malaria eradication, its deployment must be guided by precaution, robust governance, and social legitimacy to ensure safety, equity, and sustainability.